RecruitingNCT04919538
Longitudinal Study for Relapsing Polychondritis
Sponsor
University of Pennsylvania
Enrollment
100 participants
Start Date
Feb 26, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
Relapsing polychondritis (RP) is a rare systemic inflammatory disease characterized by recurrent inflammation of cartilage including ears, nose, tracheobronchial tree, chest wall and joints. Less commonly, it can cause inflammation of eyes, vasculature, nervous system, skin and inner ear. The purpose of this study is to study the pathogenesis of RP.
Eligibility
Inclusion Criteria1
- \. Any subject considered to have a diagnosis of relapsing polychondritis according to the investigator.
Exclusion Criteria1
- \. Inability to provide consent, or in the case of minors, assent.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04919538
Related Trials
Evaluation of High Dose Prednisolone Pharmacokinetics in the Acute and Chronic Setting
NCT050120331 location
Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
NCT022578661 location
Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases
NCT052514151 location
Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.
NCT0632160130 locations
An Open-Label Study of Effectiveness of Immunomodulatory Medications for Patients With Relapsing Polychondritis
NCT069413761 location